Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CFL001
- Development stage
- Phase 1
- Lead developer
- Creative Medical Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraarticular
01
Overview
CFL001 is an allogeneic, "off-the-shelf" umbilical cord blood-derived cell therapy product developed by Creative Medical Technology Holdings. Designed as a universal donor product, it utilizes a proprietary manufacturing process to ensure compatibility with current Good Manufacturing Practice (cGMP) and eliminates the need for HLA matching between the donor and recipient. The therapy is primarily indicated for Sacroiliac Joint (SIJ) Syndrome, a condition characterized by chronic back pain originating from the sacroiliac joint. CFL001 is administered via intra-articular injection, where it is intended to leverage the natural immunomodulatory and regenerative properties of cord blood cells to reduce inflammation, promote tissue repair, and alleviate symptomatic pain.
- Other names
- Allogeneic umbilical cord blood productUmbilical cord blood product
Beyond the preview
Go deeper on CFL001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CFL001.